Advisor Group Holdings, Inc. Tenaya Therapeutics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 34,000 shares of TNYA stock, worth $47,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,000
Previous 34,000
-0.0%
Holding current value
$47,600
Previous $20,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TNYA
# of Institutions
91Shares Held
36.7MCall Options Held
91.4KPut Options Held
50.3K-
Column Group LLC San Francisco, CA9.4MShares$13.2 Million8.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.76MShares$6.66 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$5.7 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.26MShares$3.16 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.84MShares$2.58 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $57.9M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...